J Gen Virol Try Microbiology Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published as JGV in Press, 10.1099/vir.0.014266-0 on July 22, 2009 J Gen Virol 90 (2009), 2592-2603; DOI 10.1099/vir.0.014266-0

IMMEDIATE OPEN ACCESS ARTICLE
This Article
Free via Open Access: OA
Right arrow OA Free Full Text
Right arrow Full Text (PDF)
Right arrowOA All Versions of this Article:
vir.0.014266-0v1
90/11/2592    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Wright, D. E.
Right arrow Articles by Stevenson, P. G.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wright, D. E.
Right arrow Articles by Stevenson, P. G.
Agricola
Right arrow Articles by Wright, D. E.
Right arrow Articles by Stevenson, P. G.

Antibody limits in vivo murid herpesvirus-4 replication by IgG Fc receptor-dependent functions

Debbie E. Wright1, Susanna Colaco1, Camilo Colaco2 and Philip G. Stevenson1

1 Division of Virology, Department of Pathology, University of Cambridge, UK
2 Immunobiology Ltd, Babraham Research Campus, Cambridge, UK

Correspondence
Philip G. Stevenson
pgs27{at}cam.ac.uk

Antibody is an important antiviral defence. However, it is considered to do little against human gamma-herpesviruses, which establish predominantly latent infections regulated by T cells. One limitation on analysing these infections has been that latency is already well-established at clinical presentation; early infection may still be accessible to antibody. Here, using murid herpesvirus-4 (MuHV-4), we tested the impact of adoptively transferred antibody on early gamma-herpesvirus infection. Immune sera and neutralizing and non-neutralizing monoclonal antibodies (mAbs) all reduced acute lytic MuHV-4 replication. The reductions, even by neutralizing mAbs, were largely or completely dependent on host IgG Fc receptors. Therefore, passive antibody can blunt acute gamma-herpesvirus lytic infection, and does this principally by IgG Fc-dependent functions rather than by neutralization.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2009 by the Society for General Microbiology.